Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
filingDate |
1994-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f6691c536a0d322cfb4431a2b30ac8d |
publicationDate |
1995-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H07324099-A |
titleOfInvention |
Cholecystokinin-B / gastrin receptor |
abstract |
(57) [Summary] [Structure] The present invention relates to the CCK-B / gastrin receptor described in SEQ ID NOS: 3 and 4 and SEQ ID NO: 6 in the sequence listing, and a gene encoding the same. [Effect] The CCK-B / gastrin receptor can be obtained, and it is useful for screening and evaluation of the receptor antagonist for human diseases such as gastric acid secretion inhibitor and anxiolytic agent. |
priorityDate |
1994-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |